Some studies have also suggested that miRNAs may be involved in altering the properties of cancer cells in individuals with OSA, and, more specifically, that particular miRNAs underlie the differential responses observed in melanoma cells with serine/threonine kinase 11(STK11) gene mutations when exposed to exosomes from untreated OSA patients [137]. The gene discussed is STK11; the disease is melanoma.